Detalhe da pesquisa
1.
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
Dig Dis Sci
; 66(3): 881-898, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303953
2.
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals.
Ann Hepatol
; 18(1): 193-202, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31113590
3.
Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results.
J Hepatol
; 68(1): 73-81, 2017 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28918131
4.
In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions.
Liver Int
; 34(7): e217-28, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251988
5.
Prognostic factors associated with upper gastrointestinal bleeding based on the French multicenter SANGHRIA trial.
Endosc Int Open
; 9(10): E1504-E1511, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34540542
6.
Risk factors for severe anaemia during telaprevir-based triple therapy: is acquired renal dysfunction the missing link?
Liver Int
; 34(6): e163-4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24571470
7.
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.
Eur J Gastroenterol Hepatol
; 31(10): 1270-1274, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31219848
8.
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH).
Presse Med
; 48(3 Pt 1): e101-e110, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853287
9.
Middle-term mortality and re-bleeding after initial diverticular bleeding: A nationwide study of 365 mostly elderly French patients.
United European Gastroenterol J
; 5(1): 119-127, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405330
10.
[Hepatitis C in prison settings: screening and therapy are improving. Comparative survey between 2000 and 2003]. / Amélioration du dépistage et du traitement de l'hépatite C en prison. Enquête comparative entre 2000 et 2003.
Presse Med
; 35(9 Pt 1): 1249-54, 2006 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-16969313
11.
Renal dysfunction associated with telaprevir-containing triple therapy for chronic hepatitis C: is early prediction possible?
Eur J Gastroenterol Hepatol
; 26(9): 996-1002, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072384
12.
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients.
World J Hepatol
; 6(9): 660-9, 2014 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25276282
13.
[Why treat hepatitis C in prisons?]. / Pourquoi soigner l'hépatite C en prison?
Gastroenterol Clin Biol
; 31(8-9 Pt 1): 657-8, 2007.
Artigo
em Francês
| MEDLINE | ID: mdl-17925762
14.
[Treatment of chronic hepatitis C in drug users: ethic, successful and useful]. / Traiter l'hépatite C chez des patients usagers de drogue et/ou précaires: éthique, efficace et utile.
Presse Med
; 43(12 Pt 1): 1314-6, 2014 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-25307441
15.
Prognosis of upper gastrointestinal bleeding in the oldest-old patients: a post hoc analysis of a prospective study.
J Am Geriatr Soc
; 58(5): 989-90, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20722829
16.
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
J Hepatol
; 36(6): 819-26, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12044534